Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical Trial.
Resource Type
Article
Authors
Haddad, Tufia C. ; Suman, Vera J. ; D'Assoro, Antonino B. ; Carter, Jodi M. ; Giridhar, Karthik V. ; McMenomy, Brendan P. ; Santo, Katelyn ; Mayer, Erica L. ; Karuturi, Meghan S. ; Morikawa, Aki ; Marcom, P. Kelly ; Isaacs, Claudine J. ; Oh, Sun Young ; Clark, Amy S. ; Mayer, Ingrid A. ; Keyomarsi, Khandan ; Hobday, Timothy J. ; Peethambaram, Prema P. ; O'Sullivan, Ciara C. ; Leon-Ferre, Roberto A.
Source
JAMA Oncology; Jun2023, Vol. 9 Issue 6, p815-824, 10p
Subject
Language
ISSN
23742437